Category Archives for "News"

Abattis Announces Acquisition of Fertilizer Company Nutrivida

Abattis Announces Acquisition of Fertilizer Company Nutrivida Decmber 07, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / December 7, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has signed a non-binding letter of intent dated December 6, 2018 (the “LOI”)  to acquire 100% interest […]

Read More

Abattis Bioceuticals Comments on BCSC Temporary Order

Abattis Bioceuticals Comments on BCSC Temporary Order November 27, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 27, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) comments on the news release regarding the British Columbia Securities Commission (“BCSC”) Temporary Order dated November 26, 2018. The BCSC issued a temporary […]

Read More

Abattis Bioceuticals Celebrates Release of Comfort through Vergence Naturals

ABATTIS BIOCEUTICALS CELEBRATES RELEASE OF COMFORT THROUGH VERGENCE NATURALSOctober 11, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 26, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the release of its first proprietary product, Comfort, through the Company’s wholly-owned subsidiary Vergence Naturals (“Vergence”). Comfort, a brand-new proprietary nutraceutical, which contains […]

Read More

Abattis Bioceuticals Signs National Distribution Agreement with Shefield & Sons

Abattis Bioceuticals Signs National Distribution Agreement with Shefield & Sons November 27, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 27, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the Company has signed a Distribution Agreement (the “Distribution Agreement”) with Shefield & Sons Tobacconists […]

Read More

Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank

Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank November 23, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 23, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) to acquire 100% of Select Strains Inc. (“Select Strains”). […]

Read More